ASCO Daily News: Dr. Cora Sternberg article about prostate cancer
News

ASCO Daily News: Dr. Cora Sternberg article about prostate cancer

Is There Sufficient Evidence to Intensify Systemic Therapy in Patients With Prostate Cancer Who Have M1 by PSMA-PET but Negative Conventional Imaging?

Key Points: 

  • Prostate-specific membrane antigen PET scans (PSMA-PET) are more sensitive than conventional imaging (CI); however, the clinical trial data that established the standard of care for patients with metastatic hormone-sensitive prostate cancer used CI as the arbiter of decision-making.
       
  • Integrating PSMA-PET into everyday clinical practice without prospective evidence derived from clinical trials poses significant challenges to physicians as well as potential quality-of-life effects to their patients.
       
  • These challenges will only be surmounted at the completion of new and ongoing clinical trials in which PSMA-PET replaces currently accepted CI endpoints.
Full Article may be accessed at the following URL:

https://dailynews.ascopubs.org/do/there-sufficient-evidence-intensify-systemic-therapy-patients-prostate-cancer-have-m1.

SAMUEL AND BARBARA STERNBERG ETS FOUNDATION

MORE ARTICLES